Hillaria® is a biodegradable, sterile, transparent, highly viscous gel obtained by cross-linked hyaluronic acid which is used as an anti-adhesion barrier gel.
Hillaria® contains 100 mg of cross-linked hyaluronic acid in a 5 mL single-use prefilled syringe.
Hillaria® is indicated for laparotomic or laparoscopic abdominal interventions and hysteroscopic interventions to reduce post-surgical adhesion formation.
Hillaria®, which contains cross-linked hyaluronic acid, is highly resistant to degradation and effectively helps prevent adhesion formation during the critical early period for adhesion prevention.
Hillaria® is a biodegradable, sterile, transparent, highly viscous gel obtained by cross-linked hyaluronic acid which is used as an anti-adhesion barrier gel.
Hillaria® forms a physical barrier between damaged tissues, preventing them from adhering to each other during the wound healing process.
Hillaria® is indicated for laparotomic or laparoscopic abdominal interventions and hysteroscopic interventions to reduce post-surgical adhesion formation.
Note: Do not attempt to reposition gel once applied, and do not apply additional layers of gel on top of one another.
The cross-linking of several strands of linear hyaluronic acid forms cross-linked hyaluronic acid.
This structure makes the hyaluronic acid molecule less prone to degradation by the body’s enzymes. Therefore, cross-linked hyaluronic acid has a higher molecular weight, enhanced stability, and longer persistence than linear hyaluronic acid.
Linear hyaluronic acid is converted into cross-linked hyaluronic acid in a laboratory environment under specific temperature and pH conditions using special materials known as cross-linkers.
Various studies have shown that the injection of cross-linked hyaluronic acid plays an effective role in preventing adhesions following abdominal and pelvic surgeries.
Each 5 mL syringe of Hilaria contains:
| Ingredients | Amount |
| Cross-linked hyaluronic acid | 100 mg |
| Hyaluronic acid | 10 mg |
| Sodium chloride | 34.5 mg |
| Water for injection | 5 mL |
If you need to contact Espad Pharmed, please submit your request.
Tel: (+98) 021-44631124
Email: info@espadpharmed.com
Office: Third floor, Espad Pharmed, No. 56, Azimi St., Nafisi St., Ekbatan, Tehran
Company: Simin Dasht, Karaj, Alborz, Iran
© 2025, Espad Pharmed – All Rights Reserved.